Efaproxiral: a novel radiation sensitiser

Bibliography

• Bibliography
   Google Scholar
• Papers of special note have been highlighted as either of interest (*) or of considerable interest (88) to readers.
   Google Scholar
• HALL EJ: The oxygen effect and reoxygenation. In: Radiobiology for the Radiologists (4th edition). JB Lippincott, Philadelphia, USA (1994):133–152.
   Google Scholar
• BRIZEL DM, SIBLEY GS,
   Google Scholar
• PROSNITZ LRet al.: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Lit. I Radiat. Oncol. Biol. Phys. (1997) 38:285–289.
   Google Scholar
• STADLER P, BECKER A, FELDMANN HJet al.: Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int. Oncol. Biol. Phys. (1999) 44:749–754.
   Google Scholar
• NORDSMARK M, OVERGAARD M, OVERGAARD J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother: Oncol. (1996) 41:31–39.
   Google Scholar
• FYLES AW, MILOSEVIC M, WONG Ret al: Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiothec Oncol. (1998) 48:149–156.
   PubMed Web of Science ®Google Scholar
• RAMPLING R, CRUICKSHANK G, LEWIS ADet al: Direct measurement of p02 distribution and bioreductive enzymes
   Google Scholar
• Expert Op/n. Investig. Drugs (2004) 13(5) in human malignant brain tumors. hat. J. Radial Oncol Biol. Phys. (1994)29(3):427–431.
   Google Scholar
• DE SANTIS M, BALDUCCI M, BASILICO L et al: Radiotherapy, local control and survival in brain tumors. Rays (1998) 23(3):543–548.
   PubMedGoogle Scholar
• HOCKEL M, SCHLENGER K,
   Google Scholar
• KNOOP C et al.: Oxygenation of carcinomas of the uterine cervix: evaluation by computerized 02 tension measurements. Cancer Res. (1991) 51(22):6098–6102.
   PubMed Web of Science ®Google Scholar
• GATENBY RA, KESSLER HB, ROSENBLUM JSet al.: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radial Onto] Biol. Phys. (1988) 14(5):831–838.
   PubMed Web of Science ®Google Scholar
• VAUPEL P, KALLINOWSKI F, OKUNIEFF P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. (1989) 49(23):6449–6465.
   PubMed Web of Science ®Google Scholar
• ABRAHAM DJ, MEHANA AS, WILLIAMS FL: Design, synthesis, and testing of potential antisickling reagents,
   Google Scholar
• I: halogenated benzyloxy and phenoxy acids. (1982) J. Med. Chem. 25: 1015–1017.
   Web of Science ®Google Scholar
• ABRAHAM DJ, WIREKO FC,
   Google Scholar
• RANDAD RSet al: Allosteric modifiers of hemoglobin: 2-[4-[[3,5-disubstituted anilino) carbonyl]methyllphenoxy1-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. (1992) Biochem. 31:9141–9149.
   PubMed Web of Science ®Google Scholar
• •Key articles on the pharmacological, pharmacokinetic effects of RSR13 and RPA for prognostic factors and classification in evaluating brain metastases.
   Google Scholar
• RANDAD RS, MAHRAN MA, MEHANNA, AS, ABRAHAM DJ: Allosteric modifiers of hemoglobin,
   Google Scholar
• I: design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. (1991) J. Med. Chem. 34:752–757.
   Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• RANDAD RS, MAHRAN MA, MEHANNA AS, ABRAHAM DJ: Allosteric modifiers of hemoglobin,
   Google Scholar
• I: design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. (1991) J. Med. Chem. 34:752–757.
   Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• KUNERT MP, LIARD JF, ABRAHAM D et al.: RSR13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats. Am. Physiol (1996) 271: H602–H613.
   PubMed Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• PAGEL PS, HETTRICK DA, MONTOMERY MWet al.: RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances recovery of stunned myocardium in dogs. J. Pharm. Exp. Ther: (1998) 285:1–8.
   PubMed Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• KHANDELWAL SR, LIN PS, HALL CEet al.: Increased radiation response of FSaII fibrosarcoma in C3H mice following administration of an allosteric effector of hemoglobin-oxygen affinity. RadialOncol Invest. (1996) 4:51–59.
   Google Scholar
• •See [12].
   Google Scholar
• KHANDELWAL SR, KAVANAGH BD, LIN PSet al.: RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FsaII and SCCVII tumors in C3H mice. Br: J. Cancer (1998) 79:814–820.
   Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• KHANDELWAL SR, RANDAD RS, LIN PSet al.: Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am. J. Physiol (1993) 265:H1450–H1453.
   PubMed Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• TEICHER BA, ARA G, EMI Yet al.:
   Google Scholar
• RSR13: effects on tumor oxygenation and response to therapy. (1996) Drug. Dev. Res. 38:1–11.
   Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• ROCKWELL S, KELLEY M: RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice. Radial °flea Invest. (1998) 6:199–208.
   Google Scholar
• •See [12].
   Google Scholar
• AMORINO GP, LEE H, HOLBURN GEet al.: Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13. Radial Res. (2001) 156:294–300.
   PubMed Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• CHOY H, NABID A, STEA B et al:
   Google Scholar
• Improved local control with RSR13 and concurrent radiation therapy in a phase II study for locally advanced inoperable non-small cell lung cancer. Proceedings of the 43'd Annual Meeting of the American Society for
   Google Scholar
• Therapeutic Radiology and Oncology (2001) 51 (Suppl. 1) (3):357-358.
   Google Scholar
• •Results of earlier RSR13 clinical trials.
   Google Scholar
• CHOY H, NABID A, STEA B et al.:
   Google Scholar
• Positive phase II results of RSR13 and concurrent radiation therapy after induction chemotherapy with paclitaxel and carboplatin for locally advanced non-small cell lung cancer. Proceedings of the 37" Annual Meeting of the American Society of Clinical Oncology (2001) 20:313a.
   Google Scholar
• •See [23].
   Google Scholar
• CHOY H, SCOTT C, NABID A et al.:
   Google Scholar
• Induction chemotherapy followed by concurrent RSR13 (efaproxiral) and TRT for patients with locally advanced NSCLC: mature results of a phase II study and comparison with the results from RTOG 94-10. Euro. J. of Cancer Suppl (2003) 1(5):S323.
   Google Scholar
• •See [23].
   Google Scholar
• KAVANAGH BD, KHANDELWAL SR, SCHMIDT-ULLRICH RK et al: A Phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics and pharmacodynamics. Int. J. Radial Onto]. (2001) 49(4):1133–1139.
   PubMed Web of Science ®Google Scholar
• •See [23].
   Google Scholar
• KLEINBERG L, GROSSMAN SA, PIANTADOSI S et al.: Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme. Clin. Oncol (1999) 17(8):2593–2603.
   Web of Science ®Google Scholar
• •See [23].
   Google Scholar
• KLEINBERG L, GROSSMAN SA, CARSON K et al.: Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a Phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study. Clin. Oncol (2002) 20(14):3149–3155.
   Web of Science ®Google Scholar
• •See [23].
   Google Scholar
• SHAW E, SCOTT C, SUH J et al: RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Group recursive partitioning analysis brain metastases database. J. Clin. Onto] (2003) 21:2364–2371.
   Google Scholar
• •See [23].
   Google Scholar
• VENITZ J, JOSHI G, ABRAHAM D: In vitro plasma protein (PPB) and RBC binding (RBCB) of allosteric hemoglobin 549 (Hb) modifiers in human blood. Proceedings of the 1 1th Annual Meeting of the American Association of Pharmaceutical Scientists. Seattle, WA, USA Pharm. Res (1996) 13(9):S421.
   Google Scholar
• VENITZ J, FLATTUM P, GERBER M, ABRAHAM D: Pharmacolkinetics (PK) of escalating IV doses of an allosteric hemoglobin (Hb) modifier, RSR13, in healthy volunteers. Proceedings of the 1 1th Annual Meeting of the American Association of Pharmaceutical Scientists. Seattle, WA, USA Pharm. Res (1996) 13(9):5479.
   Google Scholar
• •See [12].
   Google Scholar
• VENITZ J, GERBER M, ABRAHAM D: Pharmacological effects of escalating IV doses of an allosteric hemoglobin (Hb) modifier, RSR13, in healthy volunteers. Proceedings of the Ilth Annual Meeting of the American Association of Pharmaceutical Scientists. Seattle, WA, USA Pharm. Res. (1996) 13(9):5115.
   Google Scholar
• •See [12].
   Google Scholar
• POSNER JB. Management of brain metastases. Rev Neural. (1992) 148:477–487.
   Google Scholar
• YUNG A, SAWAYA R, CURRAN W, FULLER G: Intracranial metastatic central nervous system tumors. In: Cancer in the Nervous System. VA Levin (Ed.), Churchill Livingstone, Inc. (1996):243.
   Google Scholar
• DAVEY P Brain metastases. Curr: Pro& Cancer (1999) 23: 53–100.
   Web of Science ®Google Scholar
• GASPAR L, SCOTT C, ROTMAN M et al.: Recursive partitioning (RPA) analysis of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. hat. Radiat. Oncol. Biol. Phys. (1997) 37:745–751.
   PubMed Web of Science ®Google Scholar
• •See [12].
   Google Scholar
• GASPAR LE, SCOTT C, MURRAY K et al.: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int. .1. Radiat. Oncol Biol. Phys. (2000) 47:1001–1006.
   Google Scholar
• •See [12].
   Google Scholar
• PATCHELL RA, TIBBS PA, WALSH JWet al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Eng. J. Med. (1990) 322:494–500.
   PubMed Web of Science ®Google Scholar
• NOORDIJK EM, VECHT CJ,
   Google Scholar
• HAAXMA-REICHE H et al: The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. bit..! Rad. Oncol. Biol. Phys. (1994) 29:711–717.
   PubMed Web of Science ®Google Scholar